Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 2 Association of ZMIZ2 expression with clinical and pathological characteristics in NSCLC

From: Identification of zinc finger MIZ-type containing 2 as an oncoprotein enhancing NAD-dependent protein deacetylase sirtuin-1 deacetylase activity to regulate Wnt and Hippo pathways in non-small-cell lung cancer

Clinicopathological

N

Positive

Negative

χ2

P

Characteristics

Age (years)

  < 60

31

18

13

0.022

1.000

  ≥ 60

62

37

25

Sex

 Male

54

30

24

0.685

0.522

 Female

39

25

14

Histological type

 Squamous cell carcinoma

44

22

22

2.887

0.097

 Adenocarcinoma

49

33

16

Differentiation

 Well

33

23

10

2.359

0.186

 Moderate and poor

60

32

28

TNM classification

 I + II

61

31

30

5.079

0.028*

 III

32

24

8

Lymph node metastasis

 Negative

34

15

19

6.032

0.016*

 Positive

59

40

19

  1. * statistically significant (P<0.05)